Search research articles
Contact Us
Filters
Showing results (1-10 of 185) with videos related to
Page
of 19
Sort By:
Endocrine Pathology
|
April 1, 1997
Relevance of Somatostatin Receptors and Other Peptide Receptors in Pathology
Jean Claude Reubi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 16, 2017
In Vitro Evaluation of Molecular Tumor Targets in Nuclear Medicine: Immunohistochemistry Is One Option, but Under Which Conditions?
Jean Claude Reubi
Neuroendocrinology
|
October 13, 2004
Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment
Jean Claude Reubi
Virchows Archiv : an International Journal of Pathology
|
August 9, 2007
Peptide receptor expression in GEP-NET
Jean Claude Reubi
Current Topics in Medicinal Chemistry
|
June 23, 2007
Targeting CCK receptors in human cancers
Jean Claude Reubi
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 25, 2012
Old and new peptide receptor targets in cancer: future directions
Jean Claude Reubi
Endocrine Reviews
|
August 16, 2003
Peptide receptors as molecular targets for cancer diagnosis and therapy
Jean Claude Reubi
European Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2003
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
Jean Claude Reubi, Beatrice Waser
Trends in Pharmacological Sciences
|
November 5, 2013
Illuminating somatostatin analog action at neuroendocrine tumor receptors
Jean Claude Reubi, Agnes Schonbrunn
European Journal of Nuclear Medicine and Molecular Imaging
|
January 7, 2011
Value of the radiolabelled GLP-1 receptor antagonist exendin(9-39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans
Beatrice Waser, Jean Claude Reubi
Page
of 19
Search research articles
Search
Showing results (1-10 of 185) with videos related to
Sort By:
Page
of 19
Endocrine Pathology
|
April 1, 1997
Relevance of Somatostatin Receptors and Other Peptide Receptors in Pathology
Jean Claude Reubi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 16, 2017
In Vitro Evaluation of Molecular Tumor Targets in Nuclear Medicine: Immunohistochemistry Is One Option, but Under Which Conditions?
Jean Claude Reubi
Neuroendocrinology
|
October 13, 2004
Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment
Jean Claude Reubi
Virchows Archiv : an International Journal of Pathology
|
August 9, 2007
Peptide receptor expression in GEP-NET
Jean Claude Reubi
Current Topics in Medicinal Chemistry
|
June 23, 2007
Targeting CCK receptors in human cancers
Jean Claude Reubi
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 25, 2012
Old and new peptide receptor targets in cancer: future directions
Jean Claude Reubi
Endocrine Reviews
|
August 16, 2003
Peptide receptors as molecular targets for cancer diagnosis and therapy
Jean Claude Reubi
European Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2003
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
Jean Claude Reubi, Beatrice Waser
Trends in Pharmacological Sciences
|
November 5, 2013
Illuminating somatostatin analog action at neuroendocrine tumor receptors
Jean Claude Reubi, Agnes Schonbrunn
European Journal of Nuclear Medicine and Molecular Imaging
|
January 7, 2011
Value of the radiolabelled GLP-1 receptor antagonist exendin(9-39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans
Beatrice Waser, Jean Claude Reubi
Page
of 19